HUM Humana Inc.

Humana Works to Increase Capacity for Coronavirus Treatment

To prepare for the influx of patients who will need to be treated for coronavirus (COVID-19), Humana Inc. (NYSE: HUM) is taking steps to make it easier for members and health systems. Specifically, the national health company is lifting administrative requirements for the care of all members infected with coronavirus and for all patients in settings where capacity is stretched by the needs of those infected by coronavirus allowing for unencumbered movement from inpatient hospitals to safe, medically appropriate post-acute care settings, including home health, long-term acute care hospitals, skilled nursing facilities, etc.

Humana is asking its providers to notify them of the transitions by the following business day in order to continue care coordination for its members. Providers may visit for more information.

“Humana is working in partnership with leaders across the health care industry to ensure the system works efficiently and effectively for our country, especially as we face an onslaught of people in need of care,” said Bruce Broussard, Humana president and CEO. “It’s a fast changing environment and one in which we are committed to doing our part to remove friction to make it easier for clinicians to assist our members in getting the care they need.”

Care transitions are being facilitated for both patients being treated for COVID-19 and for all patients hospitalized in settings of COVID-related limits on health system capacity. By moving patients from hospitals to other care facilities, Humana hopes to support hospital capacity for COVID-19 treatment, especially in the locations where health care services are already strained.

In addition, Humana is continuing to provide the following resources to its members:

  • waiving member cost share for all telehealth services delivered by participating/in-network providers and accepting audio-only telephone visits for reimbursement;
  • waiving the out-of-pocket costs (copays, coinsurance and deductibles) associated with COVID-19 testing, including related visit costs in a range of clinical settings such as a physician’s office, urgent care center or emergency department;
  • allowing early prescription refills, so members can prepare for extended supply needs – an extra 30- or 90-day supply as appropriate;
  • and providing a member support line with specially trained call center employees to help support members with specific coronavirus questions and concerns, including live assistance with telehealth.

About Humana

Humana Inc. is committed to helping our millions of medical and specialty members achieve their best health. Our successful history in care delivery and health plan administration is helping us create a new kind of integrated care with the power to improve health and well-being and lower costs. Our efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

To accomplish that, we support physicians and other health care professionals as they work to deliver the right care in the right place for their patients, our members. Our range of clinical capabilities, resources and tools – such as in-home care, behavioral health, pharmacy services, data analytics and wellness solutions – combine to produce a simplified experience with the goal of making health care easier to navigate and more effective.

More information regarding Humana is available to investors via the Investor Relations page of the company’s website at humana.com, including copies of:

  • Annual reports to stockholders
  • Securities and Exchange Commission filings
  • Most recent investor conference presentations
  • Quarterly earnings news releases and conference calls
  • Calendar of events
  • Corporate Governance information.

 

EN
26/03/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Humana Inc.

Moody’s Ratings rates Humana’s senior notes Baa2; outlook negative

New York , March 3, 2025 – Moody's Ratings (Moody's) has assigned a Baa2 senior unsecured debt rating to Humana Inc.'s (Humana, NYSE: HUM, senior debt at Baa2) planned issuance of up to $1.25 billion of senior unsecured notes due in 2035 and 2055. The net proceeds of this transaction are for general...

 PRESS RELEASE

Humana Expands Value-Based Oncology Care Through New Agreement with Th...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- (NYSE: HUM), a leading health and well-being company, today introduced a new value-based care agreement with to provide comprehensive cancer care support for eligible Humana Medicare Advantage members. Value-based care is a holistic, patient-centered model designed to improve patient health outcomes and quality of life while helping to make healthcare more affordable and accessible. This press release features multimedia. View the full release here: Cancer is the in the United States, with devastating physical, emotional, and financial consequences. Huma...

 PRESS RELEASE

Humana Foundation Donates $250,000 to Support Disaster Recovery in the...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- The Humana Foundation, the philanthropic arm of (NYSE: HUM), is donating $250,000 in support of relief and recovery efforts for Kentuckians impacted by destructive flooding in Eastern Kentucky. Following the flooding, some areas were also hit by winter snowstorm activity. Over the past week, torrential rains fell across Kentucky causing flooding in some areas while overflowing rivers onto neighborhoods and communities. At least 14 people died due to storm-related issues in Eastern Kentucky. Across the storm’s path, especially in areas like Pike and Madison...

 PRESS RELEASE

Humana and Monogram Health Announce Expansion of Comprehensive Kidney ...

LOUISVILLE, Ky.--(BUSINESS WIRE)-- Humana and Monogram Health are pleased to announce a significant expansion, extending member access to in-home treatment for kidney disease and its underlying causes. Eligible Humana Medicare Advantage members in Alabama, Louisiana, Mississippi, Tennessee, and now Georgia with chronic kidney disease (CKD) and end-stage kidney disease (ESKD) will have access to Monogram’s evidence-based nephrology and multispecialty value-based care in the comfort of their homes. This press release features multimedia. View the full release here: Value-based care focuses on ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch